United States: Massachusetts

Firms: litigation

Firms: prosecution

Firms: transactions

Choate Hall & Stewart LLP

“The Choate team is cohesive – its members genuinely like and support each other, and are all exceptionally accommodating, which results in a well-rounded patent service that, from a client’s perspective, feels seamless.” Instrumental in this regard is the leadership of Charles Lyon, who – alongside Rolando Medina and Brenda Herschbach Jarrell – sets the pace for one of Boston’s destination life sciences practices.  “Charles is one of the best IP lawyers you could ever partner with. He is incredibly intelligent, with a unique ability to quickly understand the most complex concepts and synthesise large amounts of information. He distils complex webs of prior art into succinct summaries, which enables easy decision making – for example, around investment opportunities. Whether taking on work himself or appropriately delegating it, he knows precisely the status of his clients’ matters at any given time. In short, he’s a superhero who pulls it all off effortlessly.” He and Medina – a neuroscience PhD with broad patent talents – counsel Editas, a leading player in the field of gene-editing using CRISPR/Cas technology. As chair of the IP and life sciences groups, Jarrell is constantly mindful of trends in the industry and does a wonderful job keeping the practice at the cutting edge. Clients benefit readily from her support: for example, she has been by the side of genetic medicines company WAVE Life Sciences since its earliest days; it is now a public company with multiple products in clinic. Sources call her an “exceptional lawyer and terrific strategist”. Choate features prominently on the IAM Patent 1000 litigation table too, with Robert Frank and Eric Marandett in gold, Michael Bunis and Paul Popeo in silver and newcomer Sophie Wang in bronze. Frank is the statesman of the group and a former managing partner and chairman of the firm. IP litigation team captain Marandett is “the person you call for a gut check, because he’s so experienced”. He and Bunis team up very effectively, scoring high marks as “impressive lawyers who give rock-solid legal analyses along with practical, actionable advice. They have good judgement and are sensitive to business issues”. Popeo is another lawyer whom the C-suite likes to keep close, because of his strategic smarts. Cited by a gold-tier lawyer at another firm as a “huge up-and-coming talent”, Wang makes essential contributions to the group’s trial and post-grant success.

Clark+Elbing LLP 

Many of the most innovative life sciences companies rely on Clark+Elbing for the best in patent prosecution and portfolio management. The ensemble draws on a deep well of scientific, legal and business know-how to support clients globally and at the most meaningful strategic level. The first name on the team sheet is founding partner Karen L Elbing, who leads by example and produces work of stunning quality for the likes of Genentech. So too does James D DeCamp, a founding member and nearly 20-year partner with a gift for designing IP platforms from which rapid growth can be achieved. He supports Flagship Pioneering alongside Elbing and neurobiology PhD Michael J Belliveau, a seasoned attorney who keeps a laser focus on business and IP value through all phases of prosecution. Joining his colleagues in the listings this year, chemistry PhD Jeffrey Ellison more than deserves his debut. He brings deep regulatory expertise to the table and is a popular pick for international counsel. One source comments: “When my clients venture into the United States, my first choice for solid advice is Jeffrey. He is extremely reliable and legally and technically brilliant.”

Cooley LLP

Cooley’s patent offering is a compelling one; the firm has an international group of more than 110 patent lawyers and professionals who think deeply about the business side of intellectual property. Value creation is the name of the game for the eminent life sciences minds in Boston, including PhDs Heidi Erlacher, Dean Farmer and Matthew Pavao. Local partner-in-charge Erlacher helps companies to navigate crowded spaces with smart portfolio strategies and designs patent protection schemes that prioritise commercialisation opportunities and revenue growth. Farmer is well placed for complex patenting at the intersection of different scientific disciplines and has a rare ability to read the global risk picture for clients. Pavao’s gift of foresight brings sharp commercial focus to his work developing worldwide portfolios for pioneers in areas such as cancer treatment. Scott Weston leans into the life sciences practice, but also extends into mechanical and medical devices, energy and other matters. He has broad horizons and can advise holistically, tapping experience in prosecution, litigation and transactions.

Dechert LLP

Dechert’s life sciences practice is a lightning rod for praise; chief patent counsel look to hire the firm and global industry group co-head Andrea Reid at every available opportunity for their perspicacious strategic, policy and business advice and favourable prosecution and portfolio development outcomes. “An intelligent and fun lawyer to work with, Andrea is nothing short of amazing. The applications she is responsible for are superbly written, with creative claim sets, and her portfolios are some of the cleanest, best managed you’ll ever see.” Recent highlights of her sophisticated transactional practice, meanwhile, include acting for Arrakis Therapeutics on its $190 million collaboration and licensing deal with Roche to help develop a suite of RNA-targeted small molecule drugs; and handling patent strategy and diligence for Navitor Pharmaceuticals in its development and option agreement with Supernus Pharmaceuticals for mTORC1-targeted therapeutics. Chemistry PhD Chad Davis is another go-to in Boston and an essential partner to drug companies throughout all phases of the product development lifecycle.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

Globally influential boutique Finnegan is steeped in all facets of patent practice and provides one of the most complete and satisfying IP services to dynamic companies in all industries. This comprehensiveness is only enhanced by the wide-ranging capabilities of leading lights such as Eric Raciti, Linda Thayer and Leslie McDonell, who fly the firm’s flag high in Boston. Local managing partner Raciti excels as a strategist and commercial IP lawyer, but is also relied on for contentious support; upon being sued for patent infringement by OrthoAccel Technologies, Propel Orthodontics dialled his number and ended up avoiding a business-crippling preliminary injunction award against it. Maintaining litigation and prosecution talents in perfect balance, Thayer contributes on many fronts; for example, she plays an important role in Finnegan’s outstanding PTAB practice. McDonell also relishes getting to grips with the intricacies of post-grant proceedings as well as EPO oppositions, and mines a rich seam of life sciences patenting know-how in doing so.

Fish & Richardson

The crown jewel of the US legal market when it comes to patent practice, Fish is a potent force in litigation, a leader in post-grant proceedings and a global prosecution powerhouse. The firm doesn’t just have handfuls of people dotted around the country, but teams stacked with accomplished trial lawyers and high-level strategists in innovation hubs from coast to coast. The Boston group boasts incredible strength in depth across the contentious/non-contentious divide. Zooming in on the prosecution side brings superlative life sciences and medical technology practices into focus. Biochemistry PhDs Janis Fraser, Anita Meiklejohn and Christine Goddard are the anchors of the former; Peter Fasse and Michael Hamlin pillars of the latter; and Todd Garcia central to the success of both. Fraser capitalises on 25 years in the game to dispense advice that is richly laced with strategic insight; she deals with bleeding-edge innovations every day, which helps her stay out in front of the most pressing patent issues that scientific developments give rise to. Meiklejohn prosecutes with finesse in all areas of molecular biology and biochemistry; while Goddard’s previous in-house experience gives her an insider’s view of pharmaceutical product development. Fasse has an accurate read on the global patent landscape and devises clever strategies to help medical device and other clients stay two steps ahead of their competitors; Hamlin is in hot demand for opinions on diverse patent matters and for his astute approach to risk management; and Garcia provides leadership as managing principal of the Boston office. Fasse and Garcia have worked hard together to build up a valuable patent portfolio for Roche covering a complex system for automatically analysing patient blood samples. Jeffrey Barclay, meanwhile, is the go-to for anything high-technology-related; he excels at developing portfolios and extracting commercial value from them. The top names on the fight card when it comes to litigation, meanwhile, are Frank Scherkenbach and Kurt Glitzenstein. Scherkenbach has tried dozens of cases to verdict and advocates with unblemished distinction in the district courts, the ITC and at the Federal Circuit; he is currently representing Intuitive Surgical as lead counsel in an ITC case and co-pending inter partes reviews. Glitzenstein, who leads the firmwide litigation group, also brings the heat, but not just in court – he’s awesome on the prep and strategy piece, too. Proshanto Mukherji is a rare trial lawyer with a PhD (computer science), giving him an edge on the technical aspects of cases. Adam Kessel has a total command of the issues in multi-layered patent, trade secret and unfair competition actions, and is also a confident presenter. A well-rounded litigator, post-grant lawyer and counsellor, Lawrence Kolodney has made many valuable contributions to the success of both the firm and its clients; he also serves as chair of Fish’s market-leading pro bono programme.

Foley Hoag LLP

Well credentialed in the patent litigation space, Foley Hoag puts onto the playing field a crack squad of seasoned trial lawyers to afford pharmaceutical and biotechnology entities robust, technically adept and outcomes-based representation. Co-chairs of the patent litigation group Barbara Fiacco and Donald Ware put clients at ease with their assured leadership and considered strategies. Fiacco’s star is on the ascendant, not least due to his recent tenure as president of the American Intellectual Property Law Association. Experience and regulatory expertise give Ware his advantage. Philip Swain has also tried multiple cases and finds practical, business-focused resolutions whatever the brief. Foley Hoag is also gifted in prosecution and, with Dana Gordon in the fold, is always on the shortlist for in-house counsel seeking commercially on-point advice on IP planning and asset management.

Goodwin Procter LLP

Established and headquartered in Boston, Goodwin Procter has long been a model of excellence in the city and a headline act in the patent and life sciences domains. Few firms take a more integrated approach to assisting pharmaceutical and biotechnology innovators as Goodwin, whose elite prosecutors, deal lawyers and litigators work collaboratively to ensure that commercial value is created and sustained for clients. Reflecting the depth of its bench, the firm has new faces in the IAM Patent 1000 for 2021, with Christopher Denn earning recognition on the transactions table and Theresa Kavanaugh debuting on the prosecution list. Denn helms the IP transactions and strategies group and represents a prestigious and global client base that includes CRISPR Therapeutics, which he has advised on strategic collaboration and licensing agreements, among other things. Kavanaugh is hailed as “an accessible partner, good communicator and realistic optimist”; she also has “a great eye for detail and understands what matters most in protecting and successfully litigating pharmaceutical patents”. She assists Blueprint Medicines with global IP clearance, registration and maintenance; while Denn runs point for the company on transactional matters. They take their place alongside a number of illustrious colleagues, including Kingsley Taft, Stephen Charkoudian, Joel Lehrer and Duncan Greenhalgh. Taft is “pragmatic and business savvy, and uniquely able to appropriately characterise and prioritise risks within any collaboration structure”. Lehrer is “extremely creative, measured and strategic”. He comes recommended for both prosecution and transactions; as does biochemistry PhD Greenhalgh, a “consummate professional” and superb relationship partner who works wonders in positioning portfolios for commercial opportunities. Much of the group’s activity has a transformative effect on clients’ fortunes, which also holds true for the litigation contingent. Leading the line is Daryl Wiesen, a high-functioning Hatch-Waxman litigator who recently represented Fresenius and Actavis in litigation against Sanofi concerning a prostate cancer treatment. Anthony Downs is a veteran trial lawyer and former chair of the litigation practice who has consistently elevated the firm over more than three decades as a member. Douglas Kline is another former group captain who continues to show leadership. He and Elaine Blais – a font of insight on biosimilars – are lead counsel for Teva against Eli Lilly in a brand-versus-brand biologics case.

Greenberg Traurig LLP

Teeming with technical talent, Greenberg Traurig’s Boston office is a magnet for high-technology and life sciences companies seeking the best in global prosecution, portfolio management and strategic IP planning. The firm gets it all spot on – its entrepreneurially spirited lawyers really listen to clients and flexibly adapt to their needs in terms of budget and delivery, although quality always comes first, as the following testimonial for emerging technologies co-chair Chinh Pham confirms: “There are hardly words to describe the quality of the work done by Chinh and his team. They are not only incredibly skilled at writing the broadest claims, but also brilliant at navigating through challenging prior art landscapes. During prosecution, they show tenacity and skill in working with examiners to get our patents issued. They are an integral part of our enterprise and have played a critical role in the creation of immense value for us.”  Pham focuses principally on the high-technology space; his efforts are matched in the life sciences domain by PhDs Melissa Hunter-Ensor, Fang Xie and David Dykeman. Hunter-Ensor chairs the global prosecution group, but this never keeps her from giving 110% for the biotechnology, pharmaceutical, chemical and medical device companies she represents, such as Aspira Women’s Health, for which she has obtained myriad patents around the world. A gifted scientist and strategist, Xie acts for a diverse coterie of companies, academic and research institutions and investors, giving her a broad and deep understanding of the business of intellectual property. She has assisted listed clinical-stage biopharmaceutical company Provention Bio since its formation in 2017, developing and commercialising its patent portfolio to great effect alongside Dykeman, a “thought leader in global intellectual asset management who displays inexhaustible commitment to clients, colleagues and the community at large”. Also collaborating with Dykeman is Roman Fayerberg, whose international experience brings great benefit: they represent dynamic medtech provider Trividia Health and recently handled its $273 million sale to Sinocare Group, China’s leading diagnostics company.

Hamilton Brook Smith Reynolds

Hamilton Brook Smith Reynolds provides essential patent support to diverse company clients – including Fortune 500s – and demonstrates a high degree of specialisation acting for university research departments. Tailoring their service brilliantly, its professionals harness technical skill in combination with commercial acumen to deliver exactly what’s needed on the prosecution, strategic IP advisory and contentious fronts. Garnering special praise, Mark Solomon is someone to whom many look for favourable patent examination results: “Mark shows great initiative and is highly efficient in identifying and resolving problems – he makes the whole process of patent protection a smooth, satisfying and enjoyable experience.” He is also a sought-after opinion giver with a “keen ability to ascertain subtleties in competitors’ patent claims and ensure others can’t accuse his clients – with any merit – of infringement”. He anchors the electrical engineering practice while Susan Glovsky shows leadership on the biotechnology and chemistry fronts. Also warmly recommended, “Susan is extremely conscientious and has excellent judgement” stemming from her experience at the USPTO and in the courtroom.

Holland & Knight LLP

More compact in patent practice than some firms, but by no means slight, Holland & Knight staunchly protects and enforces the rights of discerning companies that pace the field in their various industries. On the prosecution side, for example, the team enjoys close and longstanding relationships with DellEMC and Nuance Communications. Taking the lead here is national prosecution practice leader Brian Colandreo, a former software engineer who covers all bases for clients. Joshua Krumholz is the go-to for trials and has some impressive work on his CV, particularly in the telecommunications sector. He recently acted for Verizon and Ericsson in an action against Traxcell Technologies; and for Ericsson and AT&T against Uniloc. The diversity of his caseload – which encompasses all kinds of IP infringements, along with various commercial suits – has sharpened his advocacy skills to the finest point.

Lando & Anastasi LLP

“The folks at Lando & Anastasi produce patent work of outstanding quality. They also understand their clients’ business objectives and maintain an excellent rapport with in-house counsel, inventors and company senior management.” This connectedness makes them doubly effective at spotting and seizing commercial IP opportunities; while their custom-built strategies yield desired outcomes on time and within budget. The chief architect of this service is Peter Lando, who inspires those he works both for and with to achieve the best. Though not engaged in hardcore litigation, there’s little else, if anything, that he cannot do in the practice: he prosecutes with precision in diverse technical areas; gets major IP-driven transactions inked; and develops futureproofed IP management and enforcement strategies. The results of his efforts are always impactful on the bottom line and IP culture of his patrons. Sitting on the management committee with Lando, Keith Noe is another pivotal member of the group. Distinguished by his wealth of in-house insight and ability to see matters from the client’s point of view, Noe unerringly calculates the most efficient path to maximum protection. He acts for Schneider Electric on prosecution and strategy matters alongside founding partner Thomas Sullivan, whose scientific fluency is matched by business sensitivity. There’s a robust litigation practice at Lando & Anastasi, too, which is spearheaded by Craig Smith: an assured representative however a dispute unfolds, he has a knack for early resolution that rights holders thoroughly appreciate.

McCarter & English LLP 

Innovative patrons of McCarter & English have a cavernous chest of resources to draw upon: the firm has more than 100 professionals (lawyers, technical specialists and patent agents) across nine regional offices with a complete command of almost all fields of science and engineering and all types of patent activity. The Boston office is the fulcrum around which an outstanding life sciences practice turns, being home to three biochemistry PhDs – Jonathan Sparks, Maria Laccotripe Zacharakis and Jill Ann Mello – and molecular biology PhD Marcie Beth Clarke. Each brings much more than scientific erudition to the table. Sparks has cracked the code of commercialising intellectual property; the versatile Zacharakis juggles global patent prosecution, IP transactions, PTAB proceedings, EPO oppositions and patent infringement matters and never drops a ball; Mello’s all-round strategic percipience keeps her practice humming; while Clarke designs and implements worldwide patent protections for clients’ platform technologies and clinical candidates. High-stakes litigation brings Lee Carl Bromberg and Erik Paul Belt to the fore: both are polished trial and appellate lawyers who can quickly grasp the complexities of any case and weave a persuasive narrative around them.

McDermott Will & Emery

Flexing wide-ranging patent capabilities and a highly integrated approach to the practice, McDermott Will & Emery dispenses holistic advice and wraparound solutions to many eminent technology names. Further enhancing the seamlessness of its service, the firm has gifted scientists and lawyers in key innovation hubs around the country, putting it right at the heart of the action and within easy reach. Its US practitioners also collaborate with their European IP colleagues, lending an international dimension to the firm’s offering. Boston is a vital cog in the machine as the home base of litigator par excellence Sarah Chapin Columbia and Edward Gordon, who was recently appointed global head of the IP transactions practice. Coming in for special praise, “Sarah has a profound understanding of legal issues but also views things from a practical perspective – she sees the details and the big picture, and manages risks skilfully. Her way of thinking is highly organised and she’s a highly persuasive trial lawyer with a way of explaining science in simple terms that juries love; she knows what kind of arguments will move the needle.” No type of case is off limits, although she has a special faculty for complex life sciences litigation – her trial victory for Amgen in its long-running battle with Sanofi and Regeneron Pharmaceuticals over drugs that lower bad cholesterol was a recent major notch in the win column.  The specifics of Gordon’s recent matters can’t be disclosed, but he has neatly woven together the IP threads of many large-scale deals, proving himself to be a silver-tongued negotiator. McDermott Will & Emery has increased its presence in the IAM Patent 1000 prosecution table for 2021 courtesy of the addition of Jenny Chen, who joined in August 2020 by way of Polsinelli. Well connected in the life sciences world and a highly capable lawyer, she has already fit right in.

McNeill Baur PLLC

A force to be reckoned with in the biotechnology and pharmaceutical industries, McNeill Baur acquits itself with distinction as a trusted prosecution and counselling partner. The group stands out for its diversity, erudition – seven of its nine leading individuals have PhDs from prestigious institutions – encyclopaedic understanding of the USPTO and unshakeable commitment; all of which are astutely leveraged to provide a high-quality, flexible and cost-effective service. One of the best tricks that founding partner Rebecca McNeill has mastered is attracting and retaining top talent; while as a practitioner, she aligns her advice with the business needs of each company on her roster, be they publicly traded or early stage. With a varied workload including prosecution, offensive and defensive EPO oppositions and due diligence assignments, she stays sharp and ready for anything.

Mintz

Mintz lights up the patent litigation scene by its deft handling of globally relevant, high-impact cases in the semiconductor foundry, microprocessor and circuit technology arenas, breaking new ground on issues such as standard essentiality. IP chair Michael Renaud has driven the practice to great heights both as a poised litigator and above all as a stellar strategist: “Mike is extremely good at developing cases, budgeting appropriately and assessing the scope and shape of the risk confronting his clients. Plenty of lawyers have the technical ability to handle complex patent matters, but Mike has a special understanding of and sensitivity to business issues that sets him apart. He has an incredibly effective ability to orchestrate multi-pronged litigation campaigns that extend into foreign jurisdictions such as Germany and China.” He also “sees the potential for monetisation in a portfolio and leverages a detailed understanding of broader industry issues that makes him the ideal partner for the C-suite”. This puts him in pole position to implement integrated licensing and enforcement programmes for the likes of Innovative Foundry Technologies; he has also recorded some stunning results at the ITC, including a $5.5 billion win for GlobalFoundries against its largest direct competitor, Taiwan Semiconductor Manufacturing. A leading light on SEPs, James Wodarski – like Renaud – is nominated to both the IAM Patent 1000 and the IAM Strategy 300. He also brings the heat in ITC matters and, together with Renaud and Thomas Wintner, secured a limited exclusion order award against a German biotechnology company on behalf of Glycosyn, a pioneer in the field of human milk oligosaccharides – another fight between arch competitors. Wintner shines in trial courts, at the Federal Circuit, at the PTAB and in arbitral forums, with a talent for complex pharmaceutical and biotechnology litigations. Mintz blends sophistication in litigation, prosecution and counselling to fulfil the role of a strategic and business, rather than just pure legal, partner. Lisa Adams, William Geary, and Peter Corless form a high-calibre line-up equipped to assist life sciences, chemical, medical and other technology companies throughout the innovation process and product lifecycle. Geary is a go-to for patent and technology commercialisation for clients such as Janssen Pharmaceuticals, which he supports in its acquisition of technologies from innovative companies; Corless is a staunch global patent and brand protector for his corporate and university clients, including many prestigious names; and Adams debuts in the rankings this year in recognition of her accomplished performances for Baker Hughes, managing a high volume of patent prosecution; and at the other end of the company spectrum, for start-up Droplette – which has developed a needle-free skincare device for below-surface ingredient delivery – in developing its patent portfolio.

Morgan, Lewis & Bockius LLP

Morgan Lewis is all things to stakeholders in the life sciences patent community: the firm tackles big-ticket litigations (see Mike Abernathy in Chicago) and procures and monetises patents in a way that creates significant commercial value. For the latter, the offices of Stephen Altieri and Mark Hayman in Boston are the destination of choice. Altieri loves exploring state-of-the-art biotechnology innovations and has an instinctive ability to synthesise the science with the business picture. He also understands the in-house point of view and adroitly fine tunes his advice for easy absorption. Putting his negotiation skills on display, he recently helped emerging Boston-based biotechnology company Orionis Biosciences to close a collaboration agreement and equity investment with Novartis. Possessed – like Altieri – of exceptional scientific credentials, Hayman has a flair for maximising patent and regulatory exclusivities. Moving to the high-technology side of the practice brings Steven Frank into view: he’s a talented deal lawyer who also shines in patent procurement for prestigious patrons such as Harvard University, for which he prosecutes in the computer technologies area.

Nixon Peabody LLP 

Nixon Peabody’s patent practice is certainly well specced: in total, the firm has 64 patent professionals (52 of them lawyers and 15 of them PhDs) and inspiring leaders stationed in multiple major markets – including DC, Boston, Chicago and Los Angeles – who power through 1,000-plus US patent filings a year and myriad litigations in hotspots such as Delaware, the Eastern District of Texas and Northern California. It enjoys a sterling reputation among corporates as well academic and research institutions, with representation of the latter a significant area of specialisation for many years. Boston-based David Resnick and Ronald I Eisenstein, for example, are long-term collaborators with Harvard University, which they have recently been assisting with prosecution matters relating to covid-19. The distinguished Resnick sets the quality benchmark high as a portfolio manager and prosecution attorney. “Strategic and innovative”, Eisenstein “combines excellent analytical skills with a pragmatic mindset” and “goes above and beyond to serve the best business interests of his clients”. Another linchpin of the life sciences practice, Mark James FitzGerald, also garners vocal praise: “He is an exceptional attorney and has become one of the faces of microbiome intellectual property; he knows the IP package of all the leading companies in the space and has his finger on the pulse of the patent challenges they face. Mark is refreshing because he isn’t someone you need to teach or train – he is unique in the breadth of his knowledge, is great to brainstorm with and is someone you can trust to manage your portfolio and define your IP strategy. He’s nothing short of incredible to work with.” Outside of his microbiomes niche, he fields diverse life sciences mandates and manages an extensive portfolio of patents for Boston University alongside Eisenstein.

Proskauer Rose LLP

Recommended on each of the IAM Patent 1000 Massachusetts tables for prosecution, litigation and transactions, Proskauer Rose presents a reassuringly well-rounded patent practice to the market. Rich in scientific expertise, dispute resolution and trial nous, and business know-how – and globally capable, thanks to a strong presence in Asia and Europe – the firm offers so much to its dedicated life sciences and technology industry followers. An absolute star of the practice, biotechnology and pharmaceutical savant Fangli Chen distinguishes herself through her dynamism, diligence and commerciality, among many other attributes. She’s a litigation strategist, post-grant lawyer and transactions and investment expert all rolled into one, so she never misses an opportunity to protect her clients or realise IP value for them. Versatility is likewise a key trait of Joseph Capraro, who heads the prosecution, technology licensing and post-grant groups. Clients such as Hypertherm – a worldwide leader in material processing systems – take full advantage of his prowess in brands and patents and his cultivated international insight.

Ropes & Gray LLP

Ropes & Gray ascends to the gold tier for patent transactions this year – there’s no denying the sophistication of its work in the area, which is global in scope, cutting edge in terms of the technologies and industries covered, and hugely impactful in terms of the value generated. One recent disclosable deal that attests to this is David McIntosh’s representation of Massachusetts-based Sarepta Therapeutics in a collaboration and licensing agreement giving Roche exclusive rights to launch and commercialise its investigational single-treatment gene therapy for Duchenne muscular dystrophy outside the United States; the agreement is one of the biggest research-stage, single-product deals by upfront value, with Sarepta receiving a payment of $1.5 billion. Ed Black is the other heavyweight of the Boston team. He relishes the opportunity for creativity that transactional work gives him and regularly breaks new ground in the deal space.

Sunstein LLP 

The solid technological underpinnings on which Sunstein’s IP platform is based promote a high degree of efficiency in all areas of its practice, including patents. The dedicated patent group applies a rigorously commercial mindset in carrying out its prosecution and portfolio management assignments; this translates into the creation of enforceable assets that also appeal to acquisitive companies and potential licensing partners. Bruce D Sunstein sets the standard when it comes to patent quality; highly respected for his IP wisdom, he is regularly called on as an expert witness and arbitrator. Skilled in the arts of advocacy and prosecution, Robert M Asher runs point for a post-grant practice that is never short of work or successes.

White & Case LLP 

There is immense value in the globality of White & Case’s patent counsel, putting the firm in hot demand among innovative companies which depend on coherent international strategies to fulfil their commercial imperative. In her capacity as chair of the IP group, Boston’s Anita Varma is ideally placed to maximise the value of the firm’s well-rounded IP and other capabilities for clients and ensure the delivery of a seamless service. As a practitioner, she showcases impressive range and dexterity; life sciences entities enlist her to procure enforceable patents, assist them in post-grant proceedings and biosimilar litigations, and issue opinions on patentability, freedom to operate and countless other points of interest. Her USPTO and EPO qualifications further elevate her standing on the market. Charles Larsen also has a unique profile as a US patent attorney and an English solicitor. Covering similar ground for his medical technology patrons and crossing geographic borders, he can do whatever is asked of him wherever it is needed.

Wilmer Cutler Pickering Hale and Dorr LLP

WilmerHale practises at the summit of the US patent litigation scene: it has brought together some of the world’s best trial and appellate lawyers and surrounded them with wonderful technical talent, guaranteeing compelling representation in the most legally challenging, technically dense and commercially consequential cases in all forums. Synonymous with the success of the practice, William Lee is an amazing courtroom communicator with a virtually unrivalled ability to make technically complex concepts easy to understand for factfinders and juries. Co-chair of the IP litigation group Lisa Pirozzolo is another talismanic member of the line-up in Boston and the ideal choice for many leading pharmaceutical and biotechnology companies when there’s a lot on the line. She enjoys robust backing from Colleen Superko, a source of perspicacious counsel throughout all phases of drug development who plays a crucial role in patent litigation efforts, leveraging her high-level industry knowledge and technical insight. Innovators on the high-technology side are spoilt for choice in their quest for an experienced lead counsel. Michael Summersgill fits the bill perfectly for multifaceted ITC matters with parallel inter partes review proceedings, such as client Intel’s recent dispute with R2 Semiconductor; in this one, Summersgill and the team achieved total victory, staying the ITC investigation following a victory at the PTAB which was affirmed on appeal. Cynthia Vreeland has fought the corner of EMC in numerous high-value cases, prevailing in district courts and the PTAB. A veteran of over 20 trials, many of which she has first-chaired, she knows exactly what to do when in the courtroom. Like Superko on the life sciences side, former senior hardware and software engineer Peter Dichiara partakes in a wide range of prosecution and strategic counselling activities and has a bird’s-eye view of the patent world as a result, which is of tremendous benefit in litigation. Jeffrey Johnson spearheads the technology transactions and licensing practice, which is also in the upper echelons of sophistication. Recent highlights include acting for AxonVibe in the deployment of its Essential Connector mobile app with the Metropolitan Transportation Authority, which provides alternative transportation to essential workers when the New York subways are closed for cleaning.

Wolf, Greenfield & Sacks, PC

The IAM Patent 1000 rankings reflect Wolf Greenfield’s incredible strength in patent practice: the firm has multiple individuals recommended on each table, including the highest number of any Massachusetts firm in prosecution and joint highest in transactions. Also noteworthy is the technical dexterity on display, with representatives from the life sciences, chemical, mechanical and electrical practices all making the grade. Starting with the life sciences, Edward Gates, Jeffrey Hsi, Robert Sahr and Patrick Waller have all the procurement, counselling and transactional skills that a company could wish for. Former long-time chairman Gates continues to provide the firm and its prestigious patrons with outstanding and dynamic leadership; he is an authority on university IP matters and on the business of intellectual property more broadly. Hsi has a similar gift for realising the value of intangible assets: he sees issues in the round and dispenses holistic advice on patent strategy. Former neuroscientist Sahr is a sought-after portfolio builder and opinion giver; as is Waller, a source of enlightening patent and competitor landscape analyses and a keen-eyed licensing opportunity spotter. Switching gears to the mechanical group, Neil Ferraro and Jason Honeyman provide a top-notch service to innovators from many industries. With a CV including mechanical engineering and in-house IP attorney experience, non-contentious specialist Ferraro connects on a one-to-one level with individuals at all levels of a company. Honeyman maintains vibrant practices in litigation, prosecution and deals, granting him the ability to see the big picture for clients. Anchoring the high-technology division are Randy Pritzker and Edward Russavage; they understand their commercial role and play it to perfection. Pritzker chairs the electrical and computer technologies group and is a font of wisdom on efficient and effective IP due diligence. Long-serving president and managing partner Timothy Oyer, meanwhile, focuses on chemical innovation, maintaining the highest standards of client care and service. Wolf Greenfield’s scientific and engineering know-how affords a distinct advantage in litigation and post-grant proceedings, which trial lawyer Michael Albert and inter partes review ace Richard Giunta do well to capitalise on; with them in the fold, the ensemble is always on the list of leading representatives for complex disputes.

Other recommended experts

Steven Cherny is one of the best trial lawyers at one of the most feared litigation firms, Quinn Emanuel. His intellect and litigation instincts are razor-sharp. Kristin Connarn has rich cancer research experience, which informs her prosecution, portfolio development and asset management practice. She and Bob Underwood keep Hogan Lovells out in front of the latest trends and developments in the life sciences – not just locally, but worldwide. John Iwanicki gives eminent boutique Banner Witcoff a strong presence in Boston. For more than three decades, life sciences companies of all stripes have profited from his blended prosecution and litigation skillset. Foley & Lardner’s sphere of patent operations is extremely broad – as it is for many of the firm’s individuals, John Lanza being a case in point. Instruct him on any brief involving the procurement, monetisation or enforcement of patents and he gets stellar results.

Individuals: litigation

  • Steven C Cherny - Quinn Emanuel Urquhart & Sullivan LLP
  • Sarah Chapin Columbia - McDermott Will & Emery
  • Robert S Frank Jr - Choate Hall & Stewart LLP
  • William F Lee - Wilmer Cutler Pickering Hale and Dorr LLP
  • Eric J Marandett - Choate Hall & Stewart LLP
  • Lisa J Pirozzolo - Wilmer Cutler Pickering Hale and Dorr LLP
  • Michael T Renaud - Mintz
  • Frank Scherkenbach - Fish & Richardson
  • Daryl L Wiesen - Goodwin Procter LLP
  • Erik Paul Belt - McCarter & English, LLP 
  • Elaine Herrmann Blais - Goodwin Procter LLP
  • Lee Carl Bromberg - McCarter & English, LLP 
  • Michael H Bunis - Choate Hall & Stewart LLP
  • J Anthony Downs - Goodwin Procter LLP
  • Barbara Fiacco - Foley Hoag LLP
  • Kurt L Glitzenstein - Fish & Richardson
  • Douglas J Kline - Goodwin Procter LLP
  • Lawrence Kolodney - Fish & Richardson
  • Joshua C Krumholz - Holland & Knight LLP
  • Matthew B Lowrie - Foley & Lardner LLP
  • Paul D Popeo - Choate Hall & Stewart LLP
  • Michael J Summersgill - Wilmer Cutler Pickering Hale and Dorr LLP
  • Linda J Thayer - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Donald R Ware - Foley Hoag LLP
  • Michael A Albert - Wolf, Greenfield & Sacks, PC
  • Robert M Asher - Sunstein LLP 
  • Peter M Dichiara - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jason Honeyman - Wolf, Greenfield & Sacks, PC
  • Adam Kessel - Fish & Richardson
  • Charles Larsen - White & Case LLP 
  • Proshanto Mukherji - Fish & Richardson
  • Charles Sanders - Latham & Watkins LLP
  • Craig Smith - Lando & Anastasi LLP
  • Philip C Swain - Foley Hoag LLP
  • Cynthia D Vreeland - Wilmer Cutler Pickering Hale and Dorr LLP
  • Sophie Wang - Choate Hall & Stewart LLP
  • Thomas Wintner - Mintz
  • James Wodarski - Mintz

Individuals: prosecution

  • Fangli Chen - Proskauer Rose LLP
  • Edward R Gates - Wolf, Greenfield & Sacks, PC
  • Brenda Herschbach Jarrell - Choate Hall & Stewart LLP
  • Charles E Lyon - Choate Hall & Stewart LLP
  • Anita Varma - White & Case LLP 
  • Lisa Adams - Mintz
  • Stephen Altieri - Morgan Lewis & Bockius LLP
  • Jeffrey Barclay - Fish & Richardson
  • Michael J Belliveau - Clark+Elbing LLP 
  • Joseph A Capraro Jr - Proskauer Rose LLP
  • Y Jenny Chen - McDermott Will & Emery
  • Marcie Beth Clarke - McCarter & English, LLP 
  • Brian J Colandreo - Holland & Knight LLP
  • Kristin Connarn - Hogan Lovells US LLP
  • Peter F Corless - Mintz
  • Chad Davis - Dechert LLP
  • James D DeCamp - Clark+Elbing LLP 
  • David J Dykeman - Greenberg Traurig LLP
  • Ronald I Eisenstein - Nixon Peabody LLP 
  • Karen L Elbing - Clark+Elbing LLP 
  • Jeffrey Ellison - Clark+Elbing LLP 
  • Heidi Erlacher - Cooley LLP
  • Dean Farmer - Cooley LLP
  • J Peter Fasse - Fish & Richardson
  • Roman Fayerberg - Greenberg Traurig LLP
  • Neil P Ferraro - Wolf, Greenfield & Sacks, PC
  • Mark James FitzGerald - Nixon Peabody LLP 
  • Steven Frank - Morgan Lewis & Bockius LLP
  • Janis Fraser - Fish & Richardson
  • Todd Garcia - Fish & Richardson
  • William C Geary - Mintz
  • Richard F Giunta - Wolf, Greenfield & Sacks, PC
  • Susan GL Glovsky - Hamilton Brook Smith Reynolds
  • Christine Goddard - Fish & Richardson
  • Dana M Gordon - Foley Hoag LLP
  • Edward A Gordon - McDermott Will & Emery
  • Duncan A Greenhalgh - Goodwin Procter LLP
  • Michael R Hamlin - Fish & Richardson
  • Jason Honeyman - Jason Honeyman Wolf, Greenfield & Sacks, PC
  • Melissa Hunter-Ensor - Greenberg Traurig LLP
  • John P Iwanicki - Banner & Witcoff, Ltd
  • Theresa Kavanaugh - Goodwin Procter LLP
  • Maria Laccotripe Zacharakis - McCarter & English, LLP 
  • Peter C Lando - Lando & Anastasi LLP
  • John D Lanza - Foley & Lardner LLP
  • Joel E Lehrer - Goodwin Procter LLP
  • Leslie A McDonell - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Christopher McKenna - Foley & Lardner LLP
  • Rebecca McNeill - McNeill Baur PLLC
  • Rolando Medina - Choate Hall & Stewart LLP
  • Anita L Meiklejohn - Fish & Richardson
  • Jill Ann Mello - McCarter & English, LLP 
  • Keith F Noe - Lando & Anastasi LLP
  • Timothy J Oyer - Wolf, Greenfield & Sacks, PC
  • Matthew Pavao - Cooley LLP
  • Chinh H Pham - Greenberg Traurig LLP
  • Randy Pritzker - Wolf, Greenfield & Sacks, PC
  • Eric Raciti - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Andrea LC Reid - Dechert LLP
  • David Resnick - Nixon Peabody LLP 
  • Edward J Russavage - Wolf, Greenfield & Sacks, PC
  • Robert Sahr - Wolf, Greenfield & Sacks, PC
  • Mark Solomon - Hamilton Brook Smith Reynolds
  • Jonathan Sparks - McCarter & English, LLP 
  • Thomas M Sullivan - Lando & Anastasi LLP
  • Bruce D Sunstein - Sunstein LLP 
  • Colleen Superko - Wilmer Cutler Pickering Hale and Dorr LLP
  • Linda J Thayer - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Robert H Underwood - Hogan Lovells US LLP
  • Patrick RH Waller - Wolf, Greenfield & Sacks, PC
  • Fang Xie - Greenberg Traurig LLP

Individuals: transactions

  • Edward G Black - Ropes & Gray LLP
  • Stephen G Charkoudian - Goodwin Procter LLP
  • Edward R Gates - Wolf, Greenfield & Sacks, PC
  • Kingsley Taft - Goodwin Procter LLP
  • Stephen Altieri - Morgan Lewis & Bockius LLP
  • Michael J Belliveau - Clark+Elbing LLP 
  • Joseph A Capraro Jr - Proskauer Rose LLP
  • Christopher Denn - Goodwin Procter LLP
  • David J Dykeman - Greenberg Traurig LLP
  • Steven Frank - Morgan Lewis & Bockius LLP
  • Edward A Gordon - McDermott Will & Emery
  • Duncan A Greenhalgh - Goodwin Procter LLP
  • Michael R Hamlin - Fish & Richardson
  • Mark Hayman - Morgan Lewis & Bockius LLP
  • Jason Honeyman - Wolf, Greenfield & Sacks, PC
  • Jeffrey D Hsi - Wolf, Greenfield & Sacks, PC
  • Jeffrey P Johnson - Wilmer Cutler Pickering Hale and Dorr LLP
  • Peter C Lando - Lando & Anastasi LLP
  • Charles Larsen - White & Case LLP 
  • Joel E Lehrer - Goodwin Procter LLP
  • Charles E Lyon - Choate Hall & Stewart LLP
  • David M McIntosh - Ropes & Gray LLP
  • Rolando Medina - Choate Hall & Stewart LLP
  • Warren L Nachlis - Jones Day
  • Michael T Renaud - Mintz
  • Edward J Russavage - Wolf, Greenfield & Sacks, PC
  • Anita Varma - White & Case LLP 
  • Scott Weston - Cooley LLP